Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Nov 06, 2008 by Edgar Snyder

ReliOn Insulin Syringe Recall

Relion recalls syringes

The Food and Drug Administration (FDA) has issued a warning for doctors and patients using ReliOn single-use syringes. Nearly half a million syringes, manufactured by Covidien Ltd, have been recalled because they pose a health risk to diabetic patients.

The recalled syringes could be mislabeled, leading patients to receive an insulin overdose as much as 2.5 times the intended dose. This could result in low blood sugar levels and serious health consequences, including death. During the packaging process, some syringes labeled for use with U-40 insulin were mixed with syringes labeled for use with U-100 insulin.

Wal-Mart Stores Inc sold the potentially dangerous syringes at Wal-Mart and Sam's Club from August 1 until October 8. The FDA said that Covidien has received an adverse event report linked to the lot numbered 813900.

Source: "Covidien Recalls Syringes Posing Risk to Diabetics." ABC News. November 6, 2008.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 30, 2016
September Mocktail: Apple Pie Punch
Sep 28, 2016
Pittsburgh Police Beefing Up DUI Patrols in 2017
Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers